Therapeutic targets for inhibitors of glycosylation.
Small molecule inhibitors of glycoconjugate metabolism are being exploited for therapeutic benefit in a number of human disorders. As examples of this class of compound, imino sugars, as monosaccharide mimics, have a number of advantages for compound design and synthesis to define biological activit...
Main Authors: | Alonzi, D, Butters, T |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
Targeting glycosylation as a therapeutic approach.
by: Dwek, R, et al.
Published: (2002) -
Glycosylation: disease targets and therapy.
by: Zitzmann, N, et al.
Published: (2005) -
Improved cellular inhibitors for glycoprotein processing alpha-glucosidases: biological characterisation of alkyl- and arylalkyl-N-substituted deoxynojirimycins
by: Alonzi, D, et al.
Published: (2009) -
Structure of human endo-α-1,2-mannosidase (MANEA), an antiviral host-glycosylation target
by: Sobala, Ł, et al.
Published: (2020) -
Directed Evolution of Therapeutic Antibodies Targeting Glycosylation in Cancer
by: Ron Amon, et al.
Published: (2020-09-01)